Horizon Therapeutics Public Ltd Co Quarterly Goodwill in USD from Q2 2015 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Horizon Therapeutics Public Ltd Co quarterly Goodwill history and growth rate from Q2 2015 to Q2 2023.
  • Horizon Therapeutics Public Ltd Co Goodwill for the quarter ending June 30, 2023 was $1.01B, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $1.01B $0 0% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.01B -$56.2M -5.27% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $1.01B -$56.2M -5.27% Dec 31, 2022 10-Q 2023-08-08
Q3 2022 $1.01B -$58.5M -5.47% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $1.01B -$58.5M -5.47% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $1.07B -$9.68M -0.9% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $1.07B +$653M +158% Dec 31, 2021 10-Q 2023-08-08
Q3 2021 $1.07B +$655M +158% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $1.07B +$655M +158% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $1.08B +$663M +160% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $414M $0 0% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $414M $0 0% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $414M $0 0% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $414M $0 0% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $414M $0 0% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $414M -$12.8M -3% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $414M -$12.8M -3% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $414M -$12.8M -3% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $414M -$12.8M -3% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $426M $0 0% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $426M -$1.5M -0.35% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $426M -$19.1M -4.3% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $426M -$19.1M -4.3% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $426M +$178M +71.4% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 $428M +$172M +67.2% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $446M +$190M +74.3% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 $446M +$192M +75.6% Dec 31, 2016 10-K 2019-02-27
Q3 2016 $249M -$10.4M -4.03% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $256M -$3.64M -1.4% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $256M Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $254M Dec 31, 2015 10-K 2018-02-28
Q3 2015 $259M Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $260M Jun 30, 2015 10-Q 2015-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.